Advertisement · 728 × 90
#
Hashtag
#Becton_Dickinson
Advertisement · 728 × 90
Preview
BD Unveils Next-Generation TIPS Innovation to Enhance Portal Hypertension Treatment Across EU BD has announced a new TIPS stent graft called Liverty™, aiming to improve treatment options for portal hypertension in Europe. This innovation is essential for patients with liver disease.

BD Unveils Next-Generation TIPS Innovation to Enhance Portal Hypertension Treatment Across EU #United_States #Franklin_Lakes #Becton_Dickinson #portal_hypertension #Liverty_TIPS

0 0 0 0
Preview
Rick Byrd Announced His Retirement from BD After 25 Years of Service After nearly 25 years at BD, Rick Byrd, president of the Interventional Segment, will retire, leaving a significant legacy in healthcare innovation.

Rick Byrd Announced His Retirement from BD After 25 Years of Service #United_States #medical_technology #Franklin_Lakes #Becton_Dickinson #Rick_Byrd

0 0 0 0
Preview
BD Introduces Innovative Next-Generation TIPS for Portal Hypertension Care in the EU BD has launched the Liverty™ TIPS, a new innovative device to enhance care for patients with portal hypertension in the EU.

BD Introduces Innovative Next-Generation TIPS for Portal Hypertension Care in the EU #USA #Becton_Dickinson #Franklin_Lakes,_NJ #portal_hypertension #Liverty_TIPS

0 0 0 0
Preview
BD Launches Revolutionary HemoSphere Stream™ for Noninvasive Blood Pressure Monitoring BD has introduced the HemoSphere Stream™ Module, transforming blood pressure monitoring by providing continuous, noninvasive insights for clinicians.

BD Launches Revolutionary HemoSphere Stream™ for Noninvasive Blood Pressure Monitoring #USA #Franklin_Lakes #Becton_Dickinson #HemoSphere_Stream #VitaWave_Plus

0 0 0 0
Preview
BD Introduces AI-Enabled Medication Dispensing System Across Europe BD has launched its new BD® Pyxis™ Pro Dispensing Solution in Europe, enhancing medication management through advanced automation and AI insights.

BD Introduces AI-Enabled Medication Dispensing System Across Europe #USA #Franklin_Lakes #Becton_Dickinson #BD_Incada #BD_Pyxis_Pro

0 0 0 0
Preview
BD Introduces Innovative AI-Driven Medication Dispensing System in Europe BD has launched its advanced AI-based medication dispensing solution, BD® Pyxis™ Pro, in Europe, enhancing efficiency in healthcare delivery.

BD Introduces Innovative AI-Driven Medication Dispensing System in Europe #None #Becton_Dickinson #BD_Incada #BD_Pyxis

0 0 0 0
Preview
BD Introduces Cutting-Edge AI-Based Medication Dispensing System in Europe BD has launched its Pyxis Pro Dispensing Solution and Incada Connected Care Platform in Europe, revolutionizing medication management through advanced automation and AI.

BD Introduces Cutting-Edge AI-Based Medication Dispensing System in Europe #USA #Franklin_Lakes #Becton_Dickinson #Pyxis_Pro #Incada_Platform

0 0 0 0
Preview
BD's Innovative Revello Stent Advances Iliac Artery Treatments in Europe BD has announced the CE marking of the Revello™ Vascular Covered Stent, enhancing iliac artery treatment options in Europe, addressing critical PAD challenges.

BD's Innovative Revello Stent Advances Iliac Artery Treatments in Europe #USA #Franklin_Lakes #Becton_Dickinson #Revello_Stent #Iliac_Arteries

0 0 0 0
Preview
BD Enhances Iliac Artery Treatment with Innovative Stent in the EU BD has secured CE Mark for its Revello™ Vascular Covered Stent, targeting iliac artery disease. This innovation promises improved treatment for those with peripheral artery disease in Europe.

BD Enhances Iliac Artery Treatment with Innovative Stent in the EU #United_States #Franklin_Lakes #Becton_Dickinson #CE_Mark #Revello_Stent

0 0 0 0
Preview
Becton, Dickinson and Company Outlines Tender Offer Pricing and Accepted Amounts for Securities Purchases Becton, Dickinson and Company announces the pricing details of their tender offers, shedding light on the securities accepted and purchase amounts.

Becton, Dickinson and Company Outlines Tender Offer Pricing and Accepted Amounts for Securities Purchases #United_States #medical_technology #Franklin_Lakes #Becton_Dickinson #NYSE_BDX

0 0 0 0
Preview
BD Initiates Tender Offers to Repurchase Outstanding Debt Securities Worth Up to $1.6 Billion Becton Dickinson (BD) has launched tender offers for purchasing debt securities, totaling an aggregate of $1.6 billion, focusing on improving its financial standing.

BD Initiates Tender Offers to Repurchase Outstanding Debt Securities Worth Up to $1.6 Billion #USA #Tender_Offers #BD #Franklin_Lakes #Becton_Dickinson

0 0 0 0
Preview
BD Completes Strategic Merger with Waters Corporation to Enhance Healthcare Solutions BD has successfully merged its Biosciences Diagnostic Solutions with Waters Corporation, marking a significant shift in its MedTech strategy. This transition aims to enhance healthcare innovations significantly.

BD Completes Strategic Merger with Waters Corporation to Enhance Healthcare Solutions #United_States #Waters_Corporation #Franklin_Lakes #Becton_Dickinson #Biosciences

0 0 0 0
Preview
Waters Corporation Merges with BD’s Biosciences and Diagnostic Solutions, Expanding Global Leadership Waters Corporation has completed its merger with BD's Biosciences & Diagnostic Solutions, creating a global leader in life sciences. This article details the new structure and leadership.

Waters Corporation Merges with BD’s Biosciences and Diagnostic Solutions, Expanding Global Leadership #USA #Milford #Waters_Corporation #Becton_Dickinson #Biosciences

0 0 0 0
Preview
BD Posts Strong Financial Performance for the First Quarter of Fiscal 2026 BD (Becton, Dickinson and Company) released impressive financial results for Q1 of fiscal 2026, showcasing growth in revenue and earnings. CEO Tom Polen outlines future strategies.

BD Posts Strong Financial Performance for the First Quarter of Fiscal 2026 #United_States #financial_results #BD #Franklin_Lakes #Becton_Dickinson

0 0 0 0
Preview
BD Sets Record Date for Strategic Spin-Off and Merger with Waters Corporation BD has announced the record date for its spin-off of the Biosciences & Diagnostic Solutions business, combining with Waters Corporation for optimal growth.

BD Sets Record Date for Strategic Spin-Off and Merger with Waters Corporation #USA #Waters_Corporation #Franklin_Lakes #Becton_Dickinson #Biosciences

0 0 0 0
Preview
Advancements in Immunology and Cancer Research Through BD's AI-Powered Insights and Tools BD has launched a new AI tool to enhance immunology and cancer research, improving data quality and efficiency in scientific experiments.

Advancements in Immunology and Cancer Research Through BD's AI-Powered Insights and Tools #United_States #AI_Tool #Franklin_Lakes #Becton_Dickinson #BD_Horizon

0 0 0 0
Preview
FDA Grants Clearance for BD's Innovative EnCor EnCompass™ Breast Biopsy System BD has received FDA clearance for its EnCor EnCompass™ Breast Biopsy System, enabling advanced breast disease diagnosis and treatment options. This innovative system will be available in 2026.

FDA Grants Clearance for BD's Innovative EnCor EnCompass™ Breast Biopsy System #United_States #Franklin_Lakes #Becton_Dickinson #Breast_Biopsy #EnCor_EnCompass

0 0 0 0
Preview
Shawn Bevec Takes Charge as Senior Vice President of Investor Relations at BD BD has named Shawn Bevec as Senior Vice President of Investor Relations, effective January 20, enhancing their investor communications.

Shawn Bevec Takes Charge as Senior Vice President of Investor Relations at BD #United_States #Investor_Relations #Franklin_Lakes #Becton_Dickinson #Shawn_Bevec

0 0 0 0
Preview
BD Plans to Conduct Virtual Shareholder Meeting for 2026 Year Becton, Dickinson and Company will host its Annual Shareholder Meeting on January 27, 2026, allowing shareholders to participate virtually.

BD Plans to Conduct Virtual Shareholder Meeting for 2026 Year #United_States #Annual_Meeting #BD #Franklin_Lakes #Becton_Dickinson

0 0 0 0
Preview
Investor Alert: Kahn Swick & Foti Launches Investigation into Waters Corporation Merger Deal An investigation has been launched by Kahn Swick & Foti, LLC into the merger of Waters Corporation and Becton Dickinson's Biosciences unit, assessing its fairness.

Investor Alert: Kahn Swick & Foti Launches Investigation into Waters Corporation Merger Deal #USA #Charles_C._Foti #New_Orleans #Waters_Corporation #Becton_Dickinson

0 0 0 0
Preview
BD Achieves Landmark with First Phasix™ Hernia Prevention Procedure in Greece and 85% Enrollment in U.S. Trial BD has marked a pivotal advancement in hernia prevention by conducting its first Phasix™ Mesh procedure in Greece and achieving over 85% enrollment in the U.S. PREVENT trial.

BD Achieves Landmark with First Phasix™ Hernia Prevention Procedure in Greece and 85% Enrollment in U.S. Trial #Greece #Becton_Dickinson #Thessaloniki #Phasix_Mesh #Hernia_Prevention

0 0 0 0
Preview
BD and Penn Institute Join Forces to Enhance Immunotherapy Using Advanced Flow Cytometry Techniques BD collaborates with the Penn Institute for Immunology to improve immunotherapy via advanced flow cytometry technology. Their joint study aims to profile human immune responses.

BD and Penn Institute Join Forces to Enhance Immunotherapy Using Advanced Flow Cytometry Techniques #USA #Immunotherapy #Franklin_Lakes #Becton_Dickinson #Penn_Institute

0 0 0 0
Preview
BD Continues Strong Shareholder Returns with 54th Annual Dividend Increase BD (Becton, Dickinson and Company) has declared an annual dividend increase, marking the 54th consecutive year of growth. Learn more about this achievement.

BD Continues Strong Shareholder Returns with 54th Annual Dividend Increase #USA #dividend_increase #BD #Franklin_Lakes #Becton_Dickinson

0 0 0 0
Preview
BD Reaches Key Enrollment Milestone in AGILITY Study for Revello™ Stent in PAD Treatment BD has achieved full enrollment in its AGILITY study for the Revello™ Vascular Covered Stent, critical for treating Peripheral Artery Disease (PAD).

BD Reaches Key Enrollment Milestone in AGILITY Study for Revello™ Stent in PAD Treatment #None #Franklin_Lakes #Becton_Dickinson #Peripheral_Artery_Disease #Revello_Stent

0 0 0 0
Preview
BD Achieves FDA 510(k) Clearance and CE-IVDR Certification for Enteric Bacterial Testing Panels BD has received approval from the FDA and CE for its Enteric Bacterial Panels, enhancing rapid diagnostics for gastrointestinal infections.

BD Achieves FDA 510(k) Clearance and CE-IVDR Certification for Enteric Bacterial Testing Panels #United_States #Franklin_Lakes #Becton_Dickinson #Enteric_Bacterial_Panels #BD_COR_System

0 0 0 0
Preview
BD Introduces Advanced AI Solutions for Enhanced Healthcare Connectivity and Efficiency BD has launched the BD Incada™ Connected Care Platform along with the BD Pyxis™ Pro Dispensing Solution, enhancing data integration in healthcare.

BD Introduces Advanced AI Solutions for Enhanced Healthcare Connectivity and Efficiency #United_States #Franklin_Lakes #Becton_Dickinson #BD_Incada #BD_Pyxis

0 0 0 0
Preview
BD Celebrates 65 Years of Innovation and Manufacturing Leadership in Broken Bow, Nebraska BD commemorates 65 years in Broken Bow, Nebraska, as a leader in healthcare manufacturing, while reinforcing its commitment to innovation and community.

BD Celebrates 65 Years of Innovation and Manufacturing Leadership in Broken Bow, Nebraska #United_States #Becton_Dickinson #BD_Vacutainer #Broken_Bow

1 0 0 0
Preview
BD to Showcase Innovative Medical Technologies at Wells Fargo 2025 Healthcare Conference BD, a leading global medical technology firm, will present at the Wells Fargo 2025 Healthcare Conference on September 3, showcasing advancements in health care.

BD to Showcase Innovative Medical Technologies at Wells Fargo 2025 Healthcare Conference #USA #Healthcare_Conference #medical_technology #Franklin_Lakes #Becton_Dickinson

0 0 0 0
Preview
BD Reports Impressive Financial Growth in Third Quarter Fiscal 2025 with Strong Revenue Increases BD has reported notable financial achievements in its third quarter, including a 10.4% revenue increase and growth in EPS, reflecting strong market performance and strategic initiatives.

BD Reports Impressive Financial Growth in Third Quarter Fiscal 2025 with Strong Revenue Increases #United_States #medical_technology #Fiscal_2025 #Franklin_Lakes #Becton_Dickinson

0 0 0 0
Preview
BD Achieves First Diamond Badge in MedTech for Supply Chain Resilience Across All Categories BD becomes the first company in MedTech to earn HIRC's Diamond Badge across all seven supply chain resilience categories, showcasing its commitment to excellence.

BD Achieves First Diamond Badge in MedTech for Supply Chain Resilience Across All Categories #United_States #MedTech #Franklin_Lakes #Becton_Dickinson #HIRC

0 0 0 0